Trial
NCT00735345
Chemotherapy Induction and Chemoradiotherapy in Patients With Esophageal Carcinoma
Phase IITERMINATEDSAFETYConfidence: HIGH
Sponsor
Arbeitsgemeinschaft medikamentoese Tumortherapie
Collaborators
Merck Sharp & Dohme LLC; Sanofi
Condition
Esophageal Cancer
Intervention
5-FU
Why stopped
because of safety concerns the study was terminated prematurely
Provenance
Dataset: 2026-07-02 • Source: ClinicalTrials.gov API v2 • Last update: 2015-03-09